{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:42:19Z","timestamp":1793936539508,"version":"4.8.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"\n Background<\/jats:title>\n Identifying predictors of relapse\/drug use recurrence (DUR) in real-time could allow the rapid implementation of overdose prevention interventions for those with substance use disorders (SUD). Wearable devices and phone-based applications for self-reported assessments in the patient's natural environment [e.g., ecological momentary assessment (EMA)] have potential for predicting DUR. Peer recovery support specialists (PRSS) play a critical role in reducing DUR risk. The benefits of utilizing PRSS resources in response to alerts derived from wearable technology and EMA data are unknown. This feasibility study investigates a) the use of wearable technologies\/EMA to predict physiological\/behavioral biomarkers of DUR and b) opportunities for PRSS-based interventions based on predictions.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Participants were recruited from various settings (e.g., SUD treatment, sober living), were provided a commercial wearable device (Oura ring), and were prompted daily to complete an EMA application assessing mood and substance cravings. Participants were monitored for 90 days (Baseline Phase), then randomized to the Standard of Care (SoC) or PRSS Intervention arm and followed for two 90-day phases. When machine learning algorithms detected an anomaly, an alert was sent to the participant's phone. The PRSS was sent an alert to contact participants in the PRSS Intervention arm.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 229 participants enrolled, 108 provided EMA and Oura data for \u22651 of 90 days during Baseline, Phase 1, and Phase 2; 63 provided \u226530% of the data across the 3 phases. Twenty-six were randomized to the PRSS Intervention arm, and 37 were randomized to the SoC arm. The PRSS made 483 call attempts for unique alerts; the average per participant across the study was \u223c20 (median\u2009=\u200915; range\u2009=\u20091\u201353). The PRSS intervention arm had modest but significant decreases in anxiety, stress, depression, angst composite (all\n p<\/jats:italic>\n 's\u2009&lt;\u20090.001), and maximum craving (\n p<\/jats:italic>\n \u2009=\u20090.011) relative to the SoC arm.\n <\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n This feasibility study highlights the potential benefits and barriers for using models to predict risk factors for DUR via wearable devices and EMA and supports the utility of a PRSS intervention once the model detects an elevated risk for DUR. Patient compliance and attrition must be improved to optimize this approach as a clinical tool. We discuss challenges and recommend strategies for future studies.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fdgth.2026.1744937","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:41:28Z","timestamp":1783057288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying risk factors for drug use recurrence with ecological momentary assessment, wearable technologies, and machine learning: a feasibility trial of peer recovery support specialist intervention"],"prefix":"10.3389","volume":"8","author":[{"given":"James J.","family":"Mahoney III","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Neurobehavioral Sciences , University of Virginia School of Medicine","place":["Charlottesville, VA, United States"]},{"name":"Department of Behavioral Medicine and Psychiatry, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]},{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor S.","family":"Finomore","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Marton","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda J.","family":"England","sequence":"additional","affiliation":[{"name":"Department of Behavioral Medicine and Psychiatry, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]},{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"McFoy","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Romanoff","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"Ramadan","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Zarei","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Mahyoub","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Crooks","sequence":"additional","affiliation":[{"name":"Department of Behavioral Medicine and Psychiatry, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]},{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Berry","sequence":"additional","affiliation":[{"name":"Department of Behavioral Medicine and Psychiatry, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]},{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Shirk","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Ranjan","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]},{"name":"Department of Neurosurgery, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Rezai","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]},{"name":"Department of Neurosurgery, Rockefeller Neuroscience Institute, West Virginia University School of Medicine","place":["Morgantown, WV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"B1","year":""},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/20250305008","article-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2026","journal-title":"Natl Center Health Stat"},{"key":"B3","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"Br Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jsat.2017.04.016","article-title":"Relapse to opioid use disorder after inpatient treatment: protective effect of injection naltrexone","volume":"85","author":"Nunes","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"B6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","article-title":"Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder","volume":"177","author":"Williams","year":"2020","journal-title":"Am J Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/cap.2019.0013","article-title":"Risk factors for drug overdose in young people: a systematic review of the literature","volume":"29","author":"Lyons","year":"2019","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/00952990.2025.2563052","article-title":"Increased risk of non-fatal overdose associated with broad adverse childhood experiences among people who use drugs in New York City: a latent class analysis","volume":"51","author":"Khezri","year":"2025","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B9","volume-title":"Preventing Overdose Deaths During High Risk Transition Periods","author":"Segel","year":"2024"},{"key":"B10","volume-title":"Substance Abuse and Mental Health Services Administration. Incorporating Peer Support Into Substance Use Disorder Treatment Services. Treatment Improvement Protocol (TIP) Series 64","year":"2023"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/add.16751","article-title":"Recovery support services as part of the continuum of care for alcohol or drug use disorders","volume":"120","author":"Day","year":"2025","journal-title":"Addiction"},{"key":"B12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/ADM.0000000000001285","article-title":"A nationwide survey study of recovery community centers supporting people in recovery from substance use disorder","volume":"18","author":"Hoeppner","year":"2024","journal-title":"J Addict Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/15504263.2018.1526431","article-title":"Resting heart rate variability: exploring associations with symptom severity in adults with substance use disorders and posttraumatic stress","volume":"15","author":"D\u2019Souza","year":"2019","journal-title":"J Dual Diagn"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1109\/IEMBS.2011.6090513","article-title":"Wearable sensor platform and mobile application for use in cognitive behavioral therapy for drug addiction and PTSD","volume":"2011","author":"Fletcher","year":"2011","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"110817","DOI":"10.1016\/j.drugalcdep.2023.110817","article-title":"Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications","volume":"249","author":"Mahoney","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"B16","doi-asserted-by":"publisher","first-page":"107929","DOI":"10.1016\/j.drugalcdep.2020.107929","article-title":"Wearable sensor-based detection of stress and craving in patients during treatment for substance use disorder: a mixed methods pilot study","volume":"209","author":"Carreiro","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"B17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1213\/ANE.0000000000007244","article-title":"Developing a wearable sensor-based digital biomarker of opioid dependence","volume":"141","author":"Carreiro","year":"2025","journal-title":"Anesth Analg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"111353","DOI":"10.1016\/j.drugalcdep.2024.111353","article-title":"Evaluation of a digital tool for detecting stress and craving in SUD recovery: an observational trial of accuracy and engagement","volume":"261","author":"Carreiro","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s00213-018-4966-9","article-title":"Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder","volume":"235","author":"Preston","year":"2018","journal-title":"Psychopharmacology"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1744937\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:41:29Z","timestamp":1783057289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1744937\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":19,"alternative-id":["10.3389\/fdgth.2026.1744937"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2026.1744937","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"1744937"}}